Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,172.9
10.0 (0.32%)

 

  • STI Straits Times Index
    3,172.9
    10.0 (0.32%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,563.2
    1.4 (0.09%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,645.4
    208.8 (0.79%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,924.4
    7.1 (0.24%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,391.9
    -18.3 (-0.08%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,180.1
    -3.4 (-0.06%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,105.6
    7.6 (0.36%)
    Index delayed 20 minutes
  • XAO XAO
    6,853.2
    41.1 (0.60%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 660.5M
  • Value: 996.5M
  • Rise: 176
  • Fall: 115
  • Unch: 535

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.167+0.005
SingTel3.360+0.010
Mapletree Log Tr1.690-0.040
YZJ Shipbldg SGD1.080-0.010
HPH Trust USD0.166+0.008
Golden Agri-Res0.225-0.005
Asiatic0.006-
Genting Sing0.920+0.005
Tritech0.023-0.001
Nam Cheong0.008-

World Indices

World Indices
Name Last Change
Nasdaq 8,616.2 -5.6
HSI 26,645.4 +208.8
HSCEI 10,502.5 +107.3
Jakarta 6,180.1 -3.4
Nikkei 225 23,391.9 -18.3
SSE Comp 2,924.4 +7.1
Shanghai A 3,064.3 +7.5
Shanghai B 244.2 -0.5
PSE Comp 0.0
KOSPI 2,105.6 +7.6

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

BELLUS HEALTH INC BELLUS HEALTH
Updated on 10 Dec 2019 (End of trading day)
Last (USD): 7.010 Change: +0.040 High: 7.120 Remarks: -
Change (%): +0.57 Low: 6.850
Open 6.850 Yesterday's Close 6.97
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 109,490 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.12655 Trailing EPS (USD) e -0.32542 NAV (USD) b 1.7418
PE a - Trailing PE f - Price / NAV b 4.0246
Dividend (USD) d - Cash In Hand (USD) g 0.4443 Issued & Paid-up Shares c 55,379,000
Dividend Yield (%) d - Price / Cash In Hand g 15.778 Treasury Shares h -
Beta - 75 Daysi 0.336 R-Squared - 75 Days(%)i 0.38 Market Cap (M) 388.207
Beta - 500 Daysi 0.311 R-Squared - 500 Days (%)i 0.38 Enterprise Value (M) 288.478
Piotroski F Score 2 Exchange Code BLU Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 78.8
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 09 Oct 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 05 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference BELLUS HEALTH INC NASDAQ 388.207 - - 4.0246 -
Industry Biotechnology NASDAQ 2,347.820 404.312 168.111 5.8763 0.744
Local Peer AMGEN INC NASDAQ 138,943.987 16.553 17.224 12.7157 2.393
Local Peer GILEAD SCIENCES INC NASDAQ 84,866.262 15.558 31.514 4.1189 3.444
Local Peer VERTEX PHARMACEUTICAL NASDAQ 56,642.431 27.019 26.422 10.7821 -
Local Peer BIOGEN INC NASDAQ 53,627.362 12.104 9.939 3.8316 -
Local Peer ILLUMINA INC NASDAQ 48,060.180 58.184 49.394 10.8268 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 40,368.684 16.515 18.827 3.8430 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,607.559 317.107 16.736 2.3736 -
Local Peer INCYTE CORPORATION NASDAQ 20,617.801 188.303 50.913 8.5109 -
Local Peer SEATTLE GENETICS INC NASDAQ 19,534.576 - - 10.9769 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 14,267.614 - - 4.6408 -
Local Peer GALAPAGOS NV SPON ADR REPR 1 ORD SHS NASDAQ 13,929.272 - 44.881 5.0396 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 13,583.942 - - 8.4525 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), NATERA INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ACCELERON PHARMA (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), CHEMOCENTRYX INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), ARVINAS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), NEXTCURE INC (NASDAQ), VERACYTE INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), XBIOTECH INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), KURA ONCOLOGY INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), OMEROS CORP (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), AVROBIO INC (NASDAQ), RETROPHIN INC (NASDAQ), CYTOKINETICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), ARDELYX INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), AGENUS INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), DERMIRA INC (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MACROGENICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PDL BIOPHARMA INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RECRO PHARMA INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), ANAPTYSBIO INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), COMPUGEN (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), KAMADA (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), GERON CORP (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), CABALETTA BIO INC (NASDAQ), XOMA CORP (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), IVERIC BIO INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), ATHERSYS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), ARAVIVE INC (NASDAQ), NANTKWEST INC (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CHIMERIX INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), IMV INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), INFLARX N V (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), SYNLOGIC INC (NASDAQ), OTONOMY INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), VACCINEX INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), EQUILLIUM INC (NASDAQ), COHBAR INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), TREVENA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), INMUNE BIO INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), SAVARA INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ZAFGEN INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), CONTRAFECT CORP (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SOLIGENIX INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ADVAXIS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ATYR PHARMA INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), SENESTECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), VAXART INC (NASDAQ), PRECIPIO INC (NASDAQ), TOCAGEN INC (NASDAQ), OCUGEN INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), TROVAGENE INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), SPHERIX INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Global Peer CSL ASX 128,058.856 47.731 47.731 17.1130 0.940
Global Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,664.181 81.216 23.963 5.4052 0.738
Global Peer SINO BIOPHARM HKEx 128,059.278 11.951 12.404 3.8137 0.719
Global Peer WUXI BIO HKEx 117,338.749 157.100 122.816 12.0785 -
Global Peer BEIGENE HKEx 87,571.472 - - 8.7375 -
Global Peer GENSCRIPT BIO HKEx 35,683.465 214.590 - 10.0626 -
Global Peer Lonza SGX 5,937.453 7.663 9.330 0.6935 4.766
Global Peer 3SBIO HKEx 26,720.484 17.663 21.499 2.6336 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 2,787.696 44.461 648.301 2.6934 -
Other Global Peers HAOHAI BIOTEC (HKEx), MYOVANT SCIENCES LTD (NYSE), FRONTAGE (HKEx), CKLIFE SCIENCES (HKEx), VIVA BIOTECH (HKEx), AVITA MEDICAL LTD (ASX), ASCENTAGE-B (HKEx), POLYNOVO LIMITED (ASX), KADMON HLDGS INC (NYSE), MESOBLAST LTD (ASX), SINOMAB BIO-B (HKEx), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), ARCUS BIOSCIENCES INC (NYSE), STARPHARMA HOLDINGS LIMITED (ASX), LEE'S PHARM (HKEx), TELIX PHARMACEUTIC (ASX), PFENEX INC (NYSE American), NEXT SCIENCE LTD (ASX), DPHARMA (Bursa), BBI LIFE SCI (HKEx), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), NANOVIRICIDES INC (NYSE American), UNI-BIO GROUP (HKEx), RESAPP HEALTH LIMITED (ASX), ENZO BIOCHEM INC (NYSE), PALATIN TECHNOLOGIES INC (NYSE American), LINEAGE CELL THERAPEUTICS INC (NYSE American), PYC THERAPEUTICS LIMITED (ASX), IMUGENE LIMITED (ASX), 22ND CENTURY GROUP INC (NYSE American), CYNATA THERAPEUTICS LTD (ASX), ONCOSIL MEDICAL LIMITED (ASX), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), ORTHOCELL LIMITED (ASX), CT ENTERPRISE (HKEx), PORT (SET), ARMATA PHARMACEUTICALS INC (NYSE American), ISORAY INC (NYSE American), BIOSINO BIO-TEC (HKEx), BIONOMICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ACTINOGEN MEDICAL LTD (ASX), INVEX THERAPEUTICS LTD NPV (ASX), REGENT PACIFIC (HKEx), ORAGENICS INC (NYSE American), MEMPHASYS LTD (ASX), NOVITA HEALTHCARE LTD (ASX), IBIO INC (NYSE American), PRESCIENT THERAPEUTICS LIMITED (ASX), BIOTRON (ASX), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), EXTRAWELL PHAR (HKEx), PROTEOMICS INTL LABORATORIES LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ANTEOTECH LIMITED (ASX), REGENEUS LTD (ASX), IMMURON LIMITED (ASX), CELLMID LIMITED (ASX), PATRYS LIMITED (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), Suntar Eco-City^ (SGX), ALTERITY THERAPEUTICS LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), ADALTA LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CCP TECHNOLOGIES LTD (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), MEGASUN (Bursa), MGRC (Bursa), SIENNA CANCER DIAGNOSTICS LTD (ASX), HAO WEN HLDGS (HKEx), ANATARA LIFESCIENCES LTD (ASX), MEDIBIO LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), BIOXYNE LIMITED (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AIM IMMUNOTECH INC (NYSE American), QT Vascular (SGX), BPH ENERGY LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.040
+0.57 %
10 Days ---
20 Days -+1.250
+21.70 %
Medium Term Return 3 Months --0.440
-5.91 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 5.550 - 7.880 Change From 1 Year Low +1.460 % Change From 1 Year Low (%) +26.31
Change From 1 Year High -0.870 % Change From 1 Year High (%) -11.04
2 Years Range 5.550 - 7.880 Change From 2 Years Low +1.460 % Change From 2 Years Low (%) +26.31
Change From 2 Years High -0.870 % Change From 2 Years High (%) -11.04
5 Years Range 5.550 - 7.880 Change From 5 Years Low +1.460 % Change From 5 Years Low (%) +26.31
Change From 5 Years High -0.870 % Change From 5 Years High (%) -11.04
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

Historical Price Data

Date Open High Low Close Volume VWAP
10 Dec 2019 6.850 7.120 6.850 7.010 109,490 -
09 Dec 2019 7.380 7.380 6.860 6.970 92,171 -
06 Dec 2019 6.910 7.260 6.910 7.260 135,722 -
05 Dec 2019 6.980 7.030 6.930 6.930 38,523 -
04 Dec 2019 6.810 7.000 6.630 6.970 74,033 -
03 Dec 2019 6.790 6.990 6.790 6.940 15,424 -
02 Dec 2019 6.870 7.085 6.850 6.910 169,626 -
29 Nov 2019 6.623 7.020 6.620 7.000 114,461 -
27 Nov 2019 6.800 7.070 6.800 7.010 191,381 -
26 Nov 2019 6.830 7.050 6.800 6.900 38,198 -
25 Nov 2019 7.050 7.100 6.800 7.020 52,436 -
22 Nov 2019 6.830 7.140 6.750 7.070 38,820 -
21 Nov 2019 6.630 6.970 6.620 6.780 11,777 -
20 Nov 2019 6.800 6.960 6.600 6.820 43,870 -
19 Nov 2019 6.610 7.030 6.590 6.970 106,447 -
18 Nov 2019 6.590 6.686 6.360 6.580 68,759 -
15 Nov 2019 6.090 6.690 5.570 6.550 111,765 -
14 Nov 2019 5.550 6.140 5.550 6.120 59,985 -
13 Nov 2019 6.190 6.190 5.550 5.760 44,634 -
12 Nov 2019 6.340 6.420 5.860 5.960 86,737 -
11 Nov 2019 6.460 6.500 6.250 6.470 27,722 -
08 Nov 2019 6.450 6.790 6.160 6.220 59,969 -
Summary
Current 2 Weeks
(26 Nov 2019 to 10 Dec 2019)
6.830 7.380 6.620 7.010 979,029 -
Previous 2 Weeks
(12 Nov 2019 to 25 Nov 2019)
6.340 7.380 5.860 7.020 625,230 -
4 Weeks from
(15 Oct 2019 to 11 Nov 2019)
6.600 7.380 6.408 6.470 907,186 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.